Answers are grounded in this paper and cite their sources.
The placental extracellular matrix undergoes continuous remodeling during gestation; however, collagen-related changes in spontaneous preterm birth (sPTB), preeclampsia (PE), and HELLP syndrome remain incompletely characterized. To this end, we compared placental COL1A2 and COL11A1 mRNA expression by RT-qPCR, collagen type I distribution by immunohistochemistry, and cytokine release from placental explants in pregnancies with sPTB (n = 13), PE (n = 10), HELLP syndrome (n = 10), and uncomplicated term deliveries (n = 8). COL11A1 mRNA expression levels were elevated in sPTB compared to the other study groups, while COL1A2 mRNA expression exhibited significant differences between sPTB and HELLP. Furthermore, placental explants from sPTB pregnancies exhibited higher levels of IL-6 and IL-8 release compared to those from PE and HELLP pregnancies, though not significantly higher than those from term controls. Type I collagen staining was reduced in the stem and intermediate villi of patients with preeclampsia (PE), while staining of terminal villi was observed more often in patients with HELLP and sPTB. Exploratory analyses revealed no significant COL1A2 or COL11A1 mRNA disparities between infection-associated (n = 6) and other sPTB cases (n = 7). These findings identify distinct associations between placental collagen-related measurements and clinical pregnancy outcomes. The limitations of the study include the modest sample size, gestational-age differences relative to term controls, and the absence of target-specific protein validation. These limitations preclude causal or biomarker-specific conclusions.
No takes yet. Share an insight, caveat, or question.
Busse et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: